A Double Blind, Double Dummy, Placebo Controlled Cross Over Study With a Positive Control to Investigate the Effect of a GSK Drug on Electrical Hyperalgesia and Threshold Tracking in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Raxatrigine (Primary) ; Lidocaine
- Indications Neuropathic pain
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 12 Jan 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 12 Jan 2010 Actual patient number (16) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 New trial record